Annual Accounts Payable
$7.08 M
+$2.74 M+63.21%
31 December 2023
Summary:
Kymera Therapeutics annual accounts payable is currently $7.08 million, with the most recent change of +$2.74 million (+63.21%) on 31 December 2023. During the last 3 years, it has risen by +$2.71 million (+61.97%). KYMR annual accounts payable is now at all-time high.KYMR Accounts Payable Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Accounts Payable
$6.49 M
-$16.00 K-0.25%
30 September 2024
Summary:
Kymera Therapeutics quarterly accounts payable is currently $6.49 million, with the most recent change of -$16.00 thousand (-0.25%) on 30 September 2024. Over the past year, it has increased by +$1.52 million (+30.45%). KYMR quarterly accounts payable is now -22.21% below its all-time high of $8.35 million, reached on 31 March 2021.KYMR Quarterly Accounts Payable Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
KYMR Accounts Payable Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +63.2% | +30.4% |
| 3 y3 years | +62.0% | +29.0% |
| 5 y5 years | +244.1% | - |
KYMR Accounts Payable High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3 years | at high | +76.7% | -8.2% | +173.6% |
| 5 y | 5 years | at high | +244.1% | -22.2% | +173.6% |
| alltime | all time | at high | +244.1% | -22.2% | +173.6% |
Kymera Therapeutics Accounts Payable History
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2024 | - | $6.49 M(-0.2%) |
| June 2024 | - | $6.51 M(-4.4%) |
| Mar 2024 | - | $6.81 M(-3.7%) |
| Dec 2023 | $7.08 M(+63.2%) | $7.08 M(+42.1%) |
| Sept 2023 | - | $4.98 M(+32.9%) |
| June 2023 | - | $3.75 M(-42.2%) |
| Mar 2023 | - | $6.48 M(+49.6%) |
| Dec 2022 | $4.33 M | $4.33 M(-31.5%) |
| Sept 2022 | - | $6.33 M(+166.5%) |
| June 2022 | - | $2.37 M(-7.5%) |
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2022 | - | $2.57 M(-35.9%) |
| Dec 2021 | $4.00 M(-8.3%) | $4.00 M(-20.4%) |
| Sept 2021 | - | $5.03 M(-38.4%) |
| June 2021 | - | $8.18 M(-2.0%) |
| Mar 2021 | - | $8.35 M(+91.1%) |
| Dec 2020 | $4.37 M(+33.3%) | $4.37 M(+9.8%) |
| Sept 2020 | - | $3.98 M(-0.1%) |
| June 2020 | - | $3.98 M(+21.6%) |
| Dec 2019 | $3.28 M(+59.3%) | $3.28 M |
| Dec 2018 | $2.06 M | - |
FAQ
- What is Kymera Therapeutics annual accounts payable?
- What is the all time high annual accounts payable for Kymera Therapeutics?
- What is Kymera Therapeutics annual accounts payable year-on-year change?
- What is Kymera Therapeutics quarterly accounts payable?
- What is the all time high quarterly accounts payable for Kymera Therapeutics?
- What is Kymera Therapeutics quarterly accounts payable year-on-year change?
What is Kymera Therapeutics annual accounts payable?
The current annual accounts payable of KYMR is $7.08 M
What is the all time high annual accounts payable for Kymera Therapeutics?
Kymera Therapeutics all-time high annual accounts payable is $7.08 M
What is Kymera Therapeutics annual accounts payable year-on-year change?
Over the past year, KYMR annual accounts payable has changed by +$2.74 M (+63.21%)
What is Kymera Therapeutics quarterly accounts payable?
The current quarterly accounts payable of KYMR is $6.49 M
What is the all time high quarterly accounts payable for Kymera Therapeutics?
Kymera Therapeutics all-time high quarterly accounts payable is $8.35 M
What is Kymera Therapeutics quarterly accounts payable year-on-year change?
Over the past year, KYMR quarterly accounts payable has changed by +$1.52 M (+30.45%)